Viewing Study NCT02347657


Ignite Creation Date: 2025-12-24 @ 6:52 PM
Ignite Modification Date: 2026-02-23 @ 6:24 AM
Study NCT ID: NCT02347657
Status: COMPLETED
Last Update Posted: 2018-06-12
First Post: 2015-01-12
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of VX-661 in Combination With Ivacaftor
Sponsor: Vertex Pharmaceuticals Incorporated
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cystic Fibrosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Homozygous for the F508del CFTR Mutation View